Abstract |
Fibrous sheath interacting protein 1 (FSIP1) is a cancer antigen expressed in the majority of breast cancer tissues and is associated with poor prognosis. However, the role of FSIP1 in the progression and drug sensitivity of triple-negative breast cancer (TNBC) has not been explored. Here, we show that FSIP1 deficiency by shRNA-mediated knockdown or CRISPR-Cas9-mediated knockout significantly inhibits the proliferation and invasion of TNBC cells and impairs chemotherapy-induced growth inhibition in vivo. Computational modeling predicted that FSIP1 binds to ULK1, and this was established by coimmunoprecipitation. FSIP1 deficiency promoted autophagy, enhanced AMP-activated protein kinase (AMPK) signaling, and decreased mechanistic target of rapamycin (mTOR) and Wnt/β- catenin activity. In contrast, knockdown of AMPK or inhibition of autophagy restored the sensitivity to chemotherapy drugs in TNBC cells. Our findings uncover a role of FSIP1 as well as mechanisms underlying FSIP1 action in drug sensitivity and may, therefore, aid in design of TNBC therapies.
|
Authors | Caigang Liu, Lisha Sun, Jie Yang, Tong Liu, Yongliang Yang, Se-Min Kim, Xunyan Ou, Yining Wang, Li Sun, Mone Zaidi, Maria I New, Tony Yuen, Qiyong Guo |
Journal | Proceedings of the National Academy of Sciences of the United States of America
(Proc Natl Acad Sci U S A)
Vol. 115
Issue 51
Pg. 13075-13080
(12 18 2018)
ISSN: 1091-6490 [Electronic] United States |
PMID | 30509973
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Carrier Proteins
- FSIP1 protein, human
- Seminal Plasma Proteins
- AMP-Activated Protein Kinases
|
Topics |
- AMP-Activated Protein Kinases
(genetics, metabolism)
- Antineoplastic Agents
(pharmacology)
- Autophagy
- Carrier Proteins
(genetics, metabolism)
- Cell Movement
- Cell Proliferation
- Drug Resistance, Neoplasm
- Female
- Humans
- Neoplasm Invasiveness
- Seminal Plasma Proteins
(genetics, metabolism)
- Triple Negative Breast Neoplasms
(genetics, metabolism, pathology)
- Tumor Cells, Cultured
|